FR2382695A1 - Reactif pour la mise en oeuvre de procedes d'analyse immunochimiques en presence d'un liquide aqueux et son application - Google Patents
Reactif pour la mise en oeuvre de procedes d'analyse immunochimiques en presence d'un liquide aqueux et son applicationInfo
- Publication number
- FR2382695A1 FR2382695A1 FR7806163A FR7806163A FR2382695A1 FR 2382695 A1 FR2382695 A1 FR 2382695A1 FR 7806163 A FR7806163 A FR 7806163A FR 7806163 A FR7806163 A FR 7806163A FR 2382695 A1 FR2382695 A1 FR 2382695A1
- Authority
- FR
- France
- Prior art keywords
- application
- reagent
- aqueous liquid
- analysis methods
- implementation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 3
- 238000004458 analytical method Methods 0.000 title abstract 2
- 230000000984 immunochemical effect Effects 0.000 title abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002228 disulfide group Chemical group 0.000 abstract 1
- 108010074605 gamma-Globulins Proteins 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000004445 quantitative analysis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Réactif pour la mise en oeuvre de procédés d'analyse immunochimiques en présence d'un liquide aqueux et son application. Ce réactif est constitué par un produit conjugué ou composé d'addition d'une ou plusieurs molécules d'immunoglobuline et d'une ou plusieurs entités d'un groupement marqueur, lesquelles molécules et entités sont liées les unes aux autres par des ponts renfermant le groupement disulfure -S-S-, ce produit conjugué étant soluble dans ledit liquide aqueux. Application à l'analyse quantitative de la gamma -globuline humaine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7702464A SE427505B (sv) | 1977-03-04 | 1977-03-04 | Reagens till anvendning vid immunkemiska bestemningsmetoder |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2382695A1 true FR2382695A1 (fr) | 1978-09-29 |
FR2382695B1 FR2382695B1 (fr) | 1984-07-13 |
Family
ID=20330625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7806163A Granted FR2382695A1 (fr) | 1977-03-04 | 1978-03-03 | Reactif pour la mise en oeuvre de procedes d'analyse immunochimiques en presence d'un liquide aqueux et son application |
Country Status (7)
Country | Link |
---|---|
US (1) | US4232119A (fr) |
JP (1) | JPS53130423A (fr) |
DE (1) | DE2808476C2 (fr) |
FR (1) | FR2382695A1 (fr) |
GB (1) | GB1597754A (fr) |
NL (1) | NL188544C (fr) |
SE (1) | SE427505B (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007879A1 (fr) * | 1978-08-02 | 1980-02-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Delta-5,3-céto stéroide isomérase et son application dans les dosages immunoenzymatiques |
EP0040365A1 (fr) * | 1980-05-19 | 1981-11-25 | Pharmacia Diagnostics Ab | Méthode d'essai comportant des réactions d'affinité biospécifique |
EP0065320A1 (fr) * | 1979-11-28 | 1982-11-24 | Institut Pasteur | Procédé de couplage d'un médicament avec un composé polypeptidique thiolé provenant d'un fragment de la toxine tétanique et ses applications |
EP0117693A2 (fr) * | 1983-02-25 | 1984-09-05 | The Upjohn Company | Essai immunologique à enzyme lié, trousses à réactifs et agents de couplage |
FR2586813A1 (fr) * | 1985-08-30 | 1987-03-06 | Inst Nat Sante Rech Med | Supports proteiques modifies aptes a immobiliser de facon reversible des anticorps ou des substances immunologiquement actives, et leurs applications au dosage et a la purification d'antigenes ou similaires. |
EP0214995A1 (fr) * | 1985-03-04 | 1987-03-25 | Dana Farber Cancer Inst Inc | Immunotoxine et procede de production. |
WO1988007200A1 (fr) * | 1987-03-19 | 1988-09-22 | Perry, Robert, Edward | Conjugaison d'anticorps monoclonaux |
US4888415A (en) * | 1985-03-04 | 1989-12-19 | Dana-Farber Cancer Institute, Inc. | Gelonin immunotoxin |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55136261A (en) * | 1979-04-12 | 1980-10-23 | Toyo Jozo Co Ltd | Novel compound and kit comprising it |
US4318981A (en) * | 1980-04-24 | 1982-03-09 | Miles Laboratories, Inc. | Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label |
US4486540A (en) * | 1980-07-18 | 1984-12-04 | Science Research Center, Inc. | Identification of reagins in the blood serum of allergen sensitized vertebrates |
US4696907A (en) * | 1980-07-18 | 1987-09-29 | Science Research Center, Inc. | Identification of reagins in the blood serum of allergen sensitized vertebrates |
SE8102194L (sv) * | 1981-04-06 | 1982-10-07 | Pharmacia Ab | Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna |
SE8102193L (sv) * | 1981-04-06 | 1982-10-07 | Pharmacia Ab | Terapeutiskt aktiv organisk forening och dess anvendning |
US4481298A (en) * | 1981-04-13 | 1984-11-06 | Amf Incorporated | Pre-precipitated double antibody immunoassay method |
NL8102178A (nl) * | 1981-05-02 | 1982-12-01 | Stichting Centraal Lab | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. |
FR2523445A1 (fr) * | 1982-03-17 | 1983-09-23 | Sanofi Sa | Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues |
SE8302758L (sv) * | 1983-05-17 | 1984-11-18 | Pharmacia Ab | Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening |
US4687732A (en) * | 1983-06-10 | 1987-08-18 | Yale University | Visualization polymers and their application to diagnostic medicine |
GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
US4665022A (en) * | 1984-02-17 | 1987-05-12 | The Regents Of The University Of California | Bioluminescent assay reagent and method |
US4863875A (en) * | 1985-08-26 | 1989-09-05 | Gia Research Company, L.P. | Dye labelled antibodies as reagents for use in immunoassay systems |
US4780421A (en) * | 1986-04-03 | 1988-10-25 | Sclavo Inc. | Cleavable labels for use in binding assays |
US4975532A (en) * | 1986-11-28 | 1990-12-04 | Sclavo, Inc. | Method to derivatize dextran |
US4959306A (en) * | 1986-11-28 | 1990-09-25 | Sclavo, Inc. | Labeling design for a binding assay reagent |
US5171563A (en) * | 1988-09-30 | 1992-12-15 | Neorx Corporation | Cleavable linkers for the reduction of non-target organ retention of immunoconjugates |
GB8927365D0 (en) * | 1989-12-04 | 1990-01-31 | Ici Plc | Reagent |
US5324650A (en) * | 1990-03-20 | 1994-06-28 | E. I. Du Pont De Nemours And Company | Situ process for production of conjugates |
US6274325B1 (en) * | 1990-06-25 | 2001-08-14 | Boehringer Mannheim Gmbh | Method for carrying out a homogeneous-immunoassay based on agglutination |
US5191066A (en) * | 1990-12-07 | 1993-03-02 | Abbott Laboratories | Site-specific conjugation of immunoglobulins and detectable labels |
US5470997A (en) * | 1992-04-06 | 1995-11-28 | Biosite Diagnostics Incorporated | Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels |
EP0635019B1 (fr) * | 1992-04-06 | 1999-05-26 | Biosite Diagnostics Inc. | Derives opiaces et etiquettes et conjugues de derives opiaces polypeptidiques et proteiques |
US5331109A (en) * | 1992-04-06 | 1994-07-19 | Biosite Diagnostics Incorporated | Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
US6037455A (en) * | 1992-11-09 | 2000-03-14 | Biosite Diagnostics Incorporated | Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
US5536820A (en) * | 1993-02-26 | 1996-07-16 | E. I. Du Pont De Nemours And Company | Avidin-binding azo reagents |
US5736624A (en) * | 1994-12-02 | 1998-04-07 | Abbott Laboratories | Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents |
US5795784A (en) | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
US5856194A (en) | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
US20040241688A1 (en) * | 2001-07-19 | 2004-12-02 | Cuneyt Bukusoglu | Human tissue specific drug screening procedure |
US7695752B2 (en) | 2003-01-24 | 2010-04-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target activated microtransfer |
CA2513646C (fr) * | 2003-01-24 | 2013-09-17 | Michael R. Emmert-Buck | Microtransfert active d'un element cible |
US20050176108A1 (en) * | 2003-03-13 | 2005-08-11 | Young-Min Kim | Physiologically active polypeptide conjugate having prolonged in vivo half-life |
US20040180054A1 (en) * | 2003-03-13 | 2004-09-16 | Hanmi Pharm. Co., Ltd. | Physiologically active polypeptide conjugate having prolonged in vivo half-life |
EP1877101B1 (fr) | 2005-04-28 | 2016-11-16 | Ventana Medical Systems, Inc. | Enzymes conjuguées à des anticorps par un lieur peg hétérobifonctionnel |
EP1893241A2 (fr) * | 2005-04-28 | 2008-03-05 | Ventana Medical Systems, Inc. | Nanoparticules flourescentes conjuguées á des anticorps via un linker peg |
US7957466B2 (en) * | 2005-09-16 | 2011-06-07 | Sony Corporation | Adaptive area of influence filter for moving object boundaries |
JP5199880B2 (ja) * | 2005-11-23 | 2013-05-15 | ベンタナ・メデイカル・システムズ・インコーポレーテツド | 分子コンジュゲート |
US8492098B2 (en) | 2006-02-21 | 2013-07-23 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of reaction components that affect a reaction |
US11237171B2 (en) | 2006-02-21 | 2022-02-01 | Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
ES2556627T3 (es) | 2007-08-30 | 2016-01-19 | Trustees Of Tufts College | Métodos para determinar la concentración de un analito en solución |
US20100075439A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification |
US8222047B2 (en) | 2008-09-23 | 2012-07-17 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
US20100075862A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample |
US9910040B2 (en) * | 2012-07-09 | 2018-03-06 | Sevident, Inc. | Molecular nets comprising capture agents and linking agents |
US9733242B2 (en) * | 2012-10-07 | 2017-08-15 | Sevident, Inc. | Devices for capturing analyte |
WO2011066449A1 (fr) * | 2009-11-24 | 2011-06-03 | Sevident | Dispositifs de détection de composés à analyser |
US8415171B2 (en) | 2010-03-01 | 2013-04-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
US9678068B2 (en) | 2010-03-01 | 2017-06-13 | Quanterix Corporation | Ultra-sensitive detection of molecules using dual detection methods |
WO2011109379A1 (fr) | 2010-03-01 | 2011-09-09 | Quanterix Corporation | Procédés et systèmes pour étendre la plage dynamique dans des dosages pour la détection de molécules ou de particules |
US9347946B2 (en) * | 2010-09-23 | 2016-05-24 | Biocept, Inc. | Methods and reagents for signal amplification |
US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
WO2012142301A2 (fr) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Procédé de détermination d'un protocole de traitement et/ou d'un pronostic de rétablissement d'un patient à la suite d'un traumatisme cérébral |
US9932626B2 (en) | 2013-01-15 | 2018-04-03 | Quanterix Corporation | Detection of DNA or RNA using single molecule arrays and other techniques |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4004979A (en) * | 1968-03-29 | 1977-01-25 | Agence Nationale De Valorisation De La Recherche (Anvar) | Preparation of active proteins cross-linked to inactive proteins |
US3652761A (en) * | 1969-09-04 | 1972-03-28 | Corning Glass Works | Immunochemical composites and antigen or antibody purification therewith |
SE420733B (sv) * | 1974-05-30 | 1981-10-26 | Exploaterings Ab Tbf | Gelprodukt, innehallande tiosulfatgrupper samt sett for framstellning derav |
US4002532A (en) * | 1974-10-21 | 1977-01-11 | Weltman Joel K | Enzyme conjugates |
-
1977
- 1977-03-04 SE SE7702464A patent/SE427505B/xx not_active IP Right Cessation
-
1978
- 1978-02-28 DE DE2808476A patent/DE2808476C2/de not_active Expired
- 1978-03-02 US US05/882,545 patent/US4232119A/en not_active Expired - Lifetime
- 1978-03-03 GB GB8451/78A patent/GB1597754A/en not_active Expired
- 1978-03-03 FR FR7806163A patent/FR2382695A1/fr active Granted
- 1978-03-04 JP JP2406478A patent/JPS53130423A/ja active Granted
- 1978-03-06 NL NLAANVRAGE7802451,A patent/NL188544C/xx not_active IP Right Cessation
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007879A1 (fr) * | 1978-08-02 | 1980-02-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Delta-5,3-céto stéroide isomérase et son application dans les dosages immunoenzymatiques |
FR2432713A1 (fr) * | 1978-08-02 | 1980-02-29 | Inst Nat Sante Rech Med | Application de la d5,3-ceto steroide isomerase dans les dosages immunoenzymatiques |
EP0065320A1 (fr) * | 1979-11-28 | 1982-11-24 | Institut Pasteur | Procédé de couplage d'un médicament avec un composé polypeptidique thiolé provenant d'un fragment de la toxine tétanique et ses applications |
EP0040365A1 (fr) * | 1980-05-19 | 1981-11-25 | Pharmacia Diagnostics Ab | Méthode d'essai comportant des réactions d'affinité biospécifique |
EP0117693A2 (fr) * | 1983-02-25 | 1984-09-05 | The Upjohn Company | Essai immunologique à enzyme lié, trousses à réactifs et agents de couplage |
EP0117693A3 (fr) * | 1983-02-25 | 1986-10-08 | The Upjohn Company | Essai immunologique à enzyme lié, trousses à réactifs et agents de couplage |
EP0214995A1 (fr) * | 1985-03-04 | 1987-03-25 | Dana Farber Cancer Inst Inc | Immunotoxine et procede de production. |
EP0214995A4 (fr) * | 1985-03-04 | 1987-07-22 | Dana Farber Cancer Inst Inc | Immunotoxine et procede de production. |
US4888415A (en) * | 1985-03-04 | 1989-12-19 | Dana-Farber Cancer Institute, Inc. | Gelonin immunotoxin |
FR2586813A1 (fr) * | 1985-08-30 | 1987-03-06 | Inst Nat Sante Rech Med | Supports proteiques modifies aptes a immobiliser de facon reversible des anticorps ou des substances immunologiquement actives, et leurs applications au dosage et a la purification d'antigenes ou similaires. |
EP0214053A1 (fr) * | 1985-08-30 | 1987-03-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Supports protéiques modifiés aptes à immobiliser de façon covalente ou réversible des anticorps ou des substances immunologiquement actives, et leurs applications au dosage et à la purification d'antigènes ou similaires |
WO1988007200A1 (fr) * | 1987-03-19 | 1988-09-22 | Perry, Robert, Edward | Conjugaison d'anticorps monoclonaux |
Also Published As
Publication number | Publication date |
---|---|
JPS53130423A (en) | 1978-11-14 |
NL7802451A (nl) | 1978-09-06 |
GB1597754A (en) | 1981-09-09 |
NL188544B (nl) | 1992-02-17 |
SE7702464L (sv) | 1978-09-05 |
DE2808476A1 (de) | 1978-09-07 |
JPS6145775B2 (fr) | 1986-10-09 |
US4232119A (en) | 1980-11-04 |
FR2382695B1 (fr) | 1984-07-13 |
DE2808476C2 (de) | 1986-11-06 |
SE427505B (sv) | 1983-04-11 |
NL188544C (nl) | 1993-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2382695A1 (fr) | Reactif pour la mise en oeuvre de procedes d'analyse immunochimiques en presence d'un liquide aqueux et son application | |
Springer et al. | Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody | |
FR2382696A1 (fr) | Procede et reactif pour analyses mettant en oeuvre des reactions d'affinite biospecifique | |
Drebin et al. | Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene | |
Kufe et al. | Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation | |
DE3854496D1 (de) | Peptide und antikörper, die die bindung von blutplättchen verhindern. | |
ATE248859T1 (de) | Metallion-ligand koordinationskomplexe, antikorper dagegen und tests die solche antikorper verwenden | |
LU81619A1 (fr) | Procede d'analyse pour determiner directement la concentration d'un composant libre dans un echantillon | |
Rudick et al. | Multiple sclerosis: free light chains in cerebrospinal fluid | |
Johansen et al. | T cell rosette formation in primates, pigs, and guinea pigs: The influence of immunosuppressive agents | |
ATE137533T1 (de) | Monoklonale antikörper gegen melanom | |
DE68919524D1 (de) | Schnelles Verfahren zur Analyse von Mutationen. | |
IT1193885B (it) | Lega di palladio e bagni per la sua deposizione senza elettrolisi. | |
IT1149667B (it) | Polvere di acciaio debolmente legato ottenuta mediante atomizzazione in olio e metodo per la sua produzione | |
RU94022277A (ru) | Новые 19-норстероиды, имеющие в положении 11 - бета феноксиалкилсульфонамидную или феноксиалкилсульфонилкарбамидную цепь, метод и промежуточные продукты их получения, и содержащая их фармацевтическая композиция | |
Prinz et al. | Expression of Fcϵ receptors on activated human T lymphocytes | |
FR2280076A1 (fr) | Procede pour l'analyse electrophoretique quantitative de proteines | |
Christopoulos et al. | A new type of pseudothrombocytopenia: EDTA‐mediated agglutination of platelets bearing Fab fragments of a chimaeric antibody | |
Fasler et al. | Electrophoretic properties of human IgG and its subclasses on sodium dodecyl-sulfate-polyacrylamide gel electrophoresis and immunoblots | |
Terao et al. | Identification of neighbouring protein pairs in the rat liver 40-S ribosomal subunits cross-linked with dimethyl suberimidate | |
RU2000114841A (ru) | Антитела против фосфорилированного vasp (стимулированного вазодилататором фосфопротеина), гибридомные клетки для их получения и их применение | |
BE861429A (fr) | Procede de realisation d'un melangeur statique, melangeur statique realise par ce procede et montage d'electrodes de soudage pour la mise en oeuvre de ce procede | |
Kirveskari et al. | Expression of α4-integrins on human neutrophils | |
BE854692A (fr) | Procede et composition pour analyses biologiques quantitatives | |
FR2364454A1 (fr) | Essai radioimmunologique du cortisol et nouveaux derives du cortisol utiles pour cet essai |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |